# A Safety Clinical Trial of Different Doses of MEDI-507 in the Prevention of Acute Renal Allograft Rejection

> **NCT00807794** · PHASE1 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 13 (actual)

## Conditions studied

- Kidney Diseases

## Interventions

- **DRUG:** MEDI-507
- **DRUG:** MEDI-507
- **DRUG:** MEDI-507
- **DRUG:** MEDI-507
- **DRUG:** MEDI-507

## Key facts

- **NCT ID:** NCT00807794
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-02
- **Primary completion:** 1997-11
- **Final completion:** 1998-01
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2008-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00807794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00807794, "A Safety Clinical Trial of Different Doses of MEDI-507 in the Prevention of Acute Renal Allograft Rejection". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00807794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*